BioCellgraft Revenue

Biotechnology Research • • 1-10 Employees

BioCellgraft revenue & valuation

Annual revenue	$171,110
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$547,552
Total funding	No funding

Key Contact at BioCellgraft

Michel Dard

Chief Executive Officer

Company overview

Headquarters	XX
Website	biocellgraft.com
NAICS	541714
Employees	1-10

BioCellgraft Email Formats

BioCellgraft uses 1 email format. The most common is {first initial}{last name} (e.g., jdoe@biocellgraft.com), used 100% of the time.

Format	Example	Percentage
{first initial}{last name}	jdoe@biocellgraft.com	100%

About BioCellgraft

BioCellgraft is a pioneering oral healthcare focused development and commercialization company driven by experienced dental experts and educators aimed at revolutionizing oral healthcare through groundbreaking regenerative therapies. BioCellgraft represents the epitome of innovation in oral healthcare, catering to unmet needs within the dental landscape. Our focus lies in the development and delivery of regenerative treatments that enhance both soft and hard tissues in the oral cavity. Leveraging the Human Connective Tissue Matrix (HCTM), our suite of products introduces novel possibilities in tissue regeneration. In partnership with Celularity, Inc. a publicly traded (NASDAQ) company under symbol CELU BioCellgraft exclusively licensed both the patents of as well as the use of their proprietary placental derived human connective tissue matrix, Interfyl for all the areas of application involving oral maxillofacial applications inclusive of aesthetics.

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

BioCellgraft has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

BioCellgraft has never raised funding before.

Frequently asked questions

BioCellgraft is located in XX.

BioCellgraft generates an estimated annual revenue of $171,110. This revenue figure reflects the company's market position and business performance in its industry.

BioCellgraft has an estimated valuation of $547,552. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

BioCellgraft has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at BioCellgraft

Michel Dard

Chief Executive Officer

4.8

40,000 users